Divo Dahlberg serves as the Senior Director of Oncology Program Leadership and Alliance Management at Xencor, where he leverages over 20 years of extensive experience in the biotech and pharmaceutical sectors. His current role is pivotal in steering multiple oncology and autoimmune programs, where he...
Divo Dahlberg serves as the Senior Director of Oncology Program Leadership and Alliance Management at Xencor, where he leverages over 20 years of extensive experience in the biotech and pharmaceutical sectors. His current role is pivotal in steering multiple oncology and autoimmune programs, where he collaborates closely with Clinical Development Leads to formulate and execute strategic program goals. Divo's expertise in clinical development and project management is instrumental in navigating the complexities of cell therapy, from preclinical stages through to regulatory milestones, ensuring that each program aligns with both scientific and business objectives.
In addition to his responsibilities as Program Team Lead, Divo acts as an Alliance Manager, fostering strong partnerships that enhance collaborative efforts in drug development. His role as the business owner for Competitive Intelligence allows him to provide critical insights that inform strategic decision-making, enabling Xencor to maintain a competitive edge in the rapidly evolving oncology landscape. Divo's commitment to process improvement and metrics-driven management ensures that projects are executed efficiently and effectively, while his involvement in the Leadership Development Committee underscores his dedication to nurturing talent and fostering a culture of excellence within the organization.
With a strong foundation in Good Clinical Practice (GCP) and clinical trials, Divo is adept at navigating the regulatory landscape, ensuring compliance and alignment with industry standards. His technical writing skills and ability to lead cross-functional teams further enhance his capability to drive successful outcomes in complex program environments. Divo Dahlberg's multifaceted expertise positions him as a key player in advancing Xencor's mission to develop innovative therapies that address unmet medical needs in oncology and beyond.
